Wellmarker Bio
PrivateLast Round
Series C
Aug 1, 2021
Est. Valuation
$170M
Total Funding Raised
$61.55M
Company Overview
Wellmarker Bio is a biopharmaceutical company that develops first-in-class anticancer drugs based on predictive biomarkers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Wellmarker Bio Comparables
Compare Wellmarker Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ABL Bio, Inc. | 76% | |
| MedPacto, Inc. | 76% | |
| SCBIO | 74% | |
Wellmarker Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 1, 2021 | ||||
| Series B | Jul 8, 2019 | ||||
| Series A | Nov 8, 2018 | ||||
| Seed | Apr 1, 2018 | ||||
| Corporate Funding | Dec 27, 2016 |
Wellmarker Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Seoul Investment Partners | Series C |
| The Wells Investment | Series A |
| Meritz Securities Co., Ltd. | Series A |
| Friend Investment Partners | Series A |
| GAIA Venture Partners | Series A |
| Sun & Tree Asset Management | Series B |
| NH Investment & Securities | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2025
Monthly visitors grew 2678% MoM, from 72 to 2K.
- Aug 1, 2021
$12M round with participation from GTOG Private Equity and others.
Wellmarker Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Wellmarker Bio's valuation, stock price, and market status.